Mechanism of action of glucocorticoid receptors in the growth of hepatoma cells

doi:10.3760/cma.j.cn371439-20230120-00047

Abstract

Abstract:

The glucocorticoid receptor （GR） plays a critical role in signal transduction， expression of related genes and apoptosis of cancer cells. Hepatocellular carcinoma is characterized by high aggressiveness and mortality. In the exploration of the relationship between GR and hepatocellular carcinoma， numerous studies have shown that GR has an inhibitory effect on the growth of hepatocellular carcinoma cells， which provides new ideas and methods for the clinical application of GR in the treatment of hepatocellular carcinoma.

Key words: Receptors, glucocorticoid, Liver neoplasms, Glucocorticoids

Li Jiaxuan, Feng Yinglu. Mechanism of action of glucocorticoid receptors in the growth of hepatoma cells[J]. Journal of International Oncology, 2023, 50(4): 241-243.

References 24

[1]	Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2021, 71(3): 209-249. DOI: 10.3322/caac.21660. doi: 10.3322/caac.21660
[2]	Meijer OC, Koorneef LL, Kroon J. Glucocorticoid receptor modulators[J]. Ann Endocrinol (Paris), 2018, 79(3): 107-111. DOI: 10.1016/j.ando.2018.03.004. doi: S0003-4266(18)30029-5 pmid: 29731108
[3]	Kalfeist L, Galland L, Ledys F, et al. Impact of glucocorticoid use in oncology in the immunotherapy era[J]. Cells, 2022, 11(5): 770. DOI: 10.3390/cells11050770. doi: 10.3390/cells11050770
[4]	Caratti B, Fidan M, Caratti G, et al. The glucocorticoid receptor associates with RAS complexes to inhibit cell proliferation and tumor growth[J]. Sci Signal, 2022, 15(726): eabm4452. DOI: 10.1126/scisignal.abm4452. doi: 10.1126/scisignal.abm4452
[5]	Vesting AJ, Jais A, Klemm P, et al. NIK/MAP3K14 in hepatocytes orchestrates NASH to hepatocellular carcinoma progression via JAK2/STAT5 inhibition[J]. Mol Metab, 2022, 66: 101626. DOI: 10.1016/j.molmet.2022.101626. doi: 10.1016/j.molmet.2022.101626
[6]	Whirledge S, DeFranco DB. Glucocorticoid signaling in health and disease: insights from tissue-specific GR knockout mice[J]. Endocrinology, 2018, 159(1): 46-64. DOI: 10.1210/en.2017-00728. doi: 10.1210/en.2017-00728 pmid: 29029225
[7]	Matthews LC, Berry AA, Morgan DJ, et al. Glucocorticoid receptor regulates accurate chromosome segregation and is associated with malignancy[J]. Proc Natl Acad Sci U S A, 2015, 112(17): 5479-5484. DOI: 10.1073/pnas.1411356112. doi: 10.1073/pnas.1411356112
[8]	Prekovic S, Schuurman K, Mayayo-Peralta I, et al. Glucocorticoid receptor triggers a reversible drug-tolerant dormancy state with acquired therapeutic vulnerabilities in lung cancer[J]. Nat Commun, 2021, 12(1): 4360. DOI: 10.1038/s41467-021-24537-3. doi: 10.1038/s41467-021-24537-3 pmid: 34272384
[9]	Jiang Z, Zhang C, Liu X, et al. Dexamethasone inhibits stemness maintenance and enhances chemosensitivity of hepatocellular carcinoma stem cells by inducing deSUMOylation of HIF‑1α and Oct4[J]. Int J Oncol, 2020, 57(3): 780-790. DOI: 10.3892/ijo.2020.5097. doi: 10.3892/ijo.2020.5097 pmid: 32705164
[10]	Escoter-Torres L, Caratti G, Mechtidou A, et al. Fighting the fire: mechanisms of inflammatory gene regulation by the glucocorticoid receptor[J]. Front Immunol, 2019, 10: 1859. DOI: 10.3389/fimmu.2019.01859. doi: 10.3389/fimmu.2019.01859 pmid: 31440248
[11]	Timmermans S, Vandewalle J, Libert C. Dimerization of the glucocorticoid receptor and its importance in (patho)physiology: a primer[J]. Cells, 2022, 11(4): 683. DOI: 10.3390/cells11040683. doi: 10.3390/cells11040683
[12]	Morse MA, Sun W, Kim R, et al. The role of angiogenesis in hepatocellular carcinoma[J]. Clin Cancer Res, 2019, 25(3): 912-920. DOI: 10.1158/1078-0432.CCR-18-1254. doi: 10.1158/1078-0432.CCR-18-1254 pmid: 30274981
[13]	朱金霞, 刘光伟, 杨培伟. 中医药调控Wnt/β-catenin通路治疗肝细胞癌的研究进展[J]. 中国中医基础医学杂志, 2023, 29(4): 679-686. DOI: 10.19945/j.cnki.issn.1006-3250.2023.04.011. doi: 10.19945/j.cnki.issn.1006-3250.2023.04.011
[14]	Liu B, Zhou H, Zhang T, et al. Loss of endothelial glucocorticoid receptor promotes angiogenesis via upregulation of Wnt/β-catenin pathway[J]. Angiogenesis, 2021, 24(3): 631-645. DOI: 10.1007/s10456-021-09773-x. doi: 10.1007/s10456-021-09773-x pmid: 33650028
[15]	Marchi D, van Eeden FJM. Homeostatic regulation of glucocorticoid receptor activity by hypoxia-inducible factor 1: from physiology to clinic[J]. Cells, 2021, 10(12): 3441. DOI: 10.3390/cells10123441. doi: 10.3390/cells10123441
[16]	Tian H, Zhu X, Lv Y, et al. Glucometabolic reprogramming in the hepatocellular carcinoma microenvironment: cause and effect[J]. Cancer Manag Res, 2020, 12: 5957-5974. DOI: 10.2147/CMAR.S258196. doi: 10.2147/CMAR.S258196 pmid: 32765096
[17]	Greulich F, Hemmer MC, Rollins DA, et al. There goes the neighborhood: assembly of transcriptional complexes during the regulation of metabolism and inflammation by the glucocorticoid receptor[J]. Steroids, 2016, 114: 7-15. DOI: 10.1016/j.steroids.2016.05.003. doi: S0039-128X(16)30035-6 pmid: 27192428
[18]	Ma R, Zhang W, Tang K, et al. Switch of glycolysis to gluconeogenesis by dexamethasone for treatment of hepatocarcinoma[J]. Nat Commun, 2013, 4: 2508. DOI: 10.1038/ncomms3508. doi: 10.1038/ncomms3508 pmid: 24149070
[19]	Cho JH, Lee YM, Starost MF, et al. Gene therapy prevents hepatic tumor initiation in murine glycogen storage disease type Ⅰa at the tumor-developing stage[J]. J Inherit Metab Dis, 2019, 42(3): 459-469. DOI: 10.1002/jimd.12056. doi: 10.1002/jimd.12056
[20]	Feng J, Li J, Wu L, et al. Emerging roles and the regulation of aerobic glycolysis in hepatocellular carcinoma[J]. J Exp Clin Cancer Res, 2020, 39(1): 126. DOI: 10.1186/s13046-020-01629-4. doi: 10.1186/s13046-020-01629-4
[21]	Du D, Liu C, Qin M, et al. Metabolic dysregulation and emerging therapeutical targets for hepatocellular carcinoma[J]. Acta Pharm Sin B, 2022, 12(2): 558-580. DOI: 10.1016/j.apsb.2021.09.019. doi: 10.1016/j.apsb.2021.09.019 pmid: 35256934
[22]	Gnocchi D, Sabbà C, Massimi M, et al. Metabolism as a new avenue for hepatocellular carcinoma therapy[J]. Int J Mol Sci, 2023, 24(4): 3710. DOI: 10.3390/ijms24043710. doi: 10.3390/ijms24043710
[23]	Xu L, Xia H, Ni D, et al. High-dose dexamethasone manipulates the tumor microenvironment and internal metabolic pathways in anti-tumor progression[J]. Int J Mol Sci, 2020, 21(5): 1846. DOI: 10.3390/ijms21051846. doi: 10.3390/ijms21051846
[24]	Tahmasebi-Birgani M, Ansari H, Carloni V. Defective mitosis-linked DNA damage response and chromosomal instability in liver cancer[J]. Biochim Biophys Acta Rev Cancer, 2019, 1872(1): 60-65. DOI: 10.1016/j.bbcan.2019.05.008. doi: 10.1016/j.bbcan.2019.05.008